Skip to main content
Top
Published in: Journal of Cancer Education 4/2010

01-12-2010

Help Me in My Confusion: Should We Think More About Mammography and Colonoscopy as “Preference Sensitive Care’?

Author: Joseph O’Donnell

Published in: Journal of Cancer Education | Issue 4/2010

Login to get access

Excerpt

I’m confused and I don’t know how to resolve it and so I thought I’d put it out there for all of you to ponder. …
Literature
1.
go back to reference Wennberg J (2010) Tracking medicine: a researcher’s quest to understand healthcare. Oxford University Press, New York Wennberg J (2010) Tracking medicine: a researcher’s quest to understand healthcare. Oxford University Press, New York
2.
go back to reference Hellquist BN, Duffy SW, Abdsaleh S, Bjorneld L, Bordas P, Tabar L, Vitak B, Zackrisson S, Nystrom L, Jonsson H (2010) Effectiveness of population-based service screening with mammography for women ages 40 to 49 years: evaluation of the Swedish Mammography Screening in Young Women (SCRY) Cohort. Cancer. doi:10.1002/cncr.25650 PubMed Hellquist BN, Duffy SW, Abdsaleh S, Bjorneld L, Bordas P, Tabar L, Vitak B, Zackrisson S, Nystrom L, Jonsson H (2010) Effectiveness of population-based service screening with mammography for women ages 40 to 49 years: evaluation of the Swedish Mammography Screening in Young Women (SCRY) Cohort. Cancer. doi:10.​1002/​cncr.​25650 PubMed
Metadata
Title
Help Me in My Confusion: Should We Think More About Mammography and Colonoscopy as “Preference Sensitive Care’?
Author
Joseph O’Donnell
Publication date
01-12-2010
Publisher
Springer-Verlag
Published in
Journal of Cancer Education / Issue 4/2010
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-010-0175-x

Other articles of this Issue 4/2010

Journal of Cancer Education 4/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine